-
Healthcare Resource Utilization for Patients With Transthyretin Amyloid Cardiomyopathy: A Real-World Study in Europe, Canada, and Japan
Sep 9, 2025, 16:22 PM -
Characteristics of Patients Treated With Biologic Agents for Moderate-to-Severe Atopic Dermatitis in Poland
Sep 9, 2025, 16:22 PM -
Patient Acceptance of Health Information Technologies: Comparative Insights From Wearables, TelE-Medicine, and mHealth
Sep 9, 2025, 16:22 PM -
Mortality in COPD and Cardiovascular Disease Comorbidity: Survival Analysis Using Curated Data From Brazilian Public Healthcare System (SUS)
Sep 9, 2025, 16:22 PM -
Epidemiology of Pulmonary Arterial Hypertension In France: A Real-World Study Using the French National Healthcare Database (SNDS)
Sep 9, 2025, 16:22 PM -
Challenges in Defining Target Populations: An Analysis of Orphan Drug Health Technology Assessments in Germany 2024
Sep 9, 2025, 16:22 PM -
A Balancing Act: Low-Dose Atropine Significantly Slows Pediatric Myopia Progression Without a Clinically Meaningful Risk of Rebound (Accelerated Myopia Progression Following Treatment Cessation)
Sep 9, 2025, 16:22 PM -
Trends in Epidemiology and Mortality of Patients With Bladder Cancer in Germany: A Retrospective Study Using German Claims Data
Sep 9, 2025, 16:22 PM -
Evaluation of Participation Data in the Context of Cancer Prevention
Sep 9, 2025, 16:22 PM -
Comparison of Clinical Outcome Assessment in Randomized Controlled Trials and in Observational Studies for Amyotrophic Lateral Sclerosis: A Scoping Review
Sep 9, 2025, 16:22 PM -
Trends and Disparities in Prostate Cancer Incidence Prevalence and Survival: A SEER Analysis 2000-2022
Sep 9, 2025, 16:22 PM -
Structured Expert Elicitation for Survival Outcomes: Insights From NICE Technical Support Document 26
Sep 9, 2025, 16:22 PM -
Economic Burden of the Adverse Events During Treatment of Metastatic Breast Cancer (mBC) HR-/HER2+ Patients in the Brazilian Private Healthcare System
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of STRIDE (Tremelimumab + Durvalumab) vs. Atezolizumab + Bevacizumab for Unresectable Hepatocellular Carcinoma: Qatari Payer and Societal Perspectives
Sep 9, 2025, 16:22 PM -
A Nonactive Implant for the Treatment of Chronic Gastro-esophageal Reflux Disease: A Cost-Effectiveness Evaluation From the Perspective of German Healthcare
Sep 9, 2025, 16:22 PM -
Validation of a Natural Language Processing Solution (REALLI) Compared to Manual Review by Physicians of Electronic Health Records (EHR) From Patients With HER2+ Metastatic Breast Cancer
Sep 9, 2025, 16:22 PM -
Variation in Revisions and Complications After Proximal Femoral Fracture Fixation—Association With Provider Characteristics
Sep 9, 2025, 16:22 PM -
Development of the Adelphi Caregiver Experience Questionnaire© (ACARE): A Novel Tool Designed to Measure and Understand the Burden and Quality of Life Impacts of the Caregiver Role
Sep 9, 2025, 16:22 PM -
Rising EAP Rejection Rates and Their Impact on Drug Access in France
Sep 9, 2025, 16:22 PM -
Multistakeholder Engagement to Codevelop Specifications for Economic Models: The MASH Case Study
Sep 9, 2025, 16:22 PM
